Han Biomedical Stock

Han Biomedical EBITDA per Share

The EBITDA per Share of Han Biomedical (6999.TWO) as of Aug 7, 2026 is 1.28 TWD. In the previous year, EBITDA per Share was 1.16 TWD — a change of 10.85% (higher).

EBITDA per Share

1.28TWD

YoY

10.85%

Last updated:

EBITDA per Share of Han Biomedical is 2026 1.28 TWD. EBITDA per Share of Han Biomedical was 2025 1.16 TWD. It decreases by 10.85% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Han Biomedical Stock analysis

What does Han Biomedical do? Han Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Han Biomedical stock

EBITDA per Share of Han Biomedical is 1.28 TWD in 2026.

EBITDA per Share of Han Biomedical changed from 1.16 TWD to 1.28 TWD, representing a 10.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Han Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Han Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Han Biomedical